Duration of Cefepime and Vancomycin Therapy
For moderate to severe pneumonia, administer cefepime 2 g IV every 8 hours and vancomycin 15-20 mg/kg IV every 8-12 hours for 10 days. 1, 2
Algorithmic Approach to Duration
For Pneumonia (Most Likely Indication Given This Regimen)
- Standard duration: 10 days for moderate to severe pneumonia, including hospital-acquired and ventilator-associated pneumonia 1, 2
- This applies when treating suspected Pseudomonas aeruginosa, K. pneumoniae, Enterobacter species, or MRSA
For Febrile Neutropenia
- Duration: 7 days or until resolution of neutropenia, whichever is longer 2
- Critical caveat: In patients whose fever resolves but who remain neutropenic beyond 7 days, frequently reassess the need for continued antimicrobial therapy 2
For Complicated Intra-abdominal Infections
- Duration: 7-10 days when cefepime is combined with metronidazole 2
For Skin and Soft Tissue Infections
- Duration: 10 days for moderate to severe uncomplicated infections 2
Key Dosing Principles from Guidelines
The Surviving Sepsis Campaign guidelines emphasize that initial antimicrobial therapy must be initiated with full, high-end loading doses 3. For vancomycin specifically:
- Loading dose: 25-30 mg/kg IV (based on actual body weight) to rapidly achieve target trough concentrations 3
- A 1-gram loading dose is insufficient for most patients and will fail to achieve early therapeutic levels 3
- Target trough: 15-20 mg/L with pre-dose monitoring recommended 3
For cefepime as a β-lactam antibiotic, the pharmacodynamic goal is maintaining plasma concentrations above the pathogen MIC for 100% of the dosing interval in severe infections like sepsis 3.
Critical Pitfalls to Avoid
Don't underdose initially: The expanded extracellular volume from aggressive fluid resuscitation in sepsis/septic shock leads to suboptimal drug levels 3. Loading doses are not affected by renal function, though maintenance dosing frequency is 3
Don't delay appropriate therapy: Inappropriate or delayed initial antimicrobial treatment significantly increases mortality (16.2% vs 24.7% attributable mortality) 1. Getting the antibiotic choice and dose right the first time is essential
Adjust for renal function: Both drugs require dose adjustment when creatinine clearance ≤60 mL/min 2. For cefepime with CrCl 30-60 mL/min, reduce to 2 g every 12 hours; for CrCl 11-29 mL/min, reduce to 2 g every 24 hours 2
De-escalate based on cultures: Once microbiologic data and clinical response are available, adjust or streamline therapy 1. Changing therapy after culture results may not reduce the excess mortality from initially inappropriate therapy, reinforcing the importance of appropriate empiric selection 1